HOME >> BIOLOGY >> NEWS
Louis Leakey Centennial Tribute

CHICAGO Who are we and where did we come from? In the quest to answer these fundamental questions about human origins, no one has had a greater or more lasting impact than Louis Leakey (1903-1972). In the 1930s, the patriarch of the renowned fossil-hunting family launched an intensive search for human ancestors in Africa and spearheaded the interdisciplinary approach to studying the birth and development of the human species.

Now, dozens of the world's leading anthropologists, geologists, biologists and evolutionary scientists including Meave and Louise Leakey will mark the 100th anniversary of Louis Leakey's birth at a two-day Centennial Tribute presented by The Leakey Foundation and held at The Field Museum Oct. 10-11. As well as tracing the Leakey legacy, this remarkable weekend will also review the latest discoveries and current thinking in the dynamic field of human origins.

"This two-day meeting will bring together so many leading authorities in the field of human origins that it is definitely the most impressive line-up that I have seen in my entire career," says Robert D. Martin, PhD, Provost and Vice President of Academic Affairs at The Field Museum. "The program will provide a fitting tribute to the outstanding achievements of Louis Leakey and his wife Mary, while at the same time providing a unique overview of current developments across the board. I am delighted that Meave and Louise will be participating to underscore the major contributions made by the entire Leakey family."

In conjunction with the Centennial Tribute, some of the participating scientists will visit Chicago area schools to discuss careers in science, fieldwork, research methods and conservation. True to Louis Leakey's wide-ranging approach to studying human origins which combined his interest and expertise in fossils, art, animal behavior, ethnography and conservation the Centennial Tribute will gather experts in a variety of fields, including paleoanthrop
'"/>

Contact: Greg Borzo
gborzo@fieldmuseum.org
312-665-7106
Field Museum
18-Sep-2003


Page: 1 2 3

Related biology news :

1. Bush nominates NJIT space explorer Louis Lanzerotti to NSF governing board
2. Washington University in St. Louis leads group studying aging process
3. Washington University in St. Louis plays key role in sequencing moss genome
4. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
5. Washington University in St. Louis, Monsanto Co., awarded crop protection patent
6. Treating strokes with blood cord cells holds promise, Saint Louis University rat study shows
7. Saint Louis University researchers make breakthrough towards solving the cause of cancer development
8. Two Max Planck researchers recieve the Louis-Jeantet Prize for Medicine 2003
9. University of Louisville leads project to customize ethics training for genetic researchers
10. Louisiana researcher and Washington, Pennsylvania, North Carolina companies win Presidential awards for environmentally-conscious business innovation
11. Worlds Largest Gathering Of Plant Scientists To Meet In St.Louis, August 1-7, 1999

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Louis Leakey Centennial Tribute

(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... 15, 2014 Sandata Technologies, LLC, an ... community-based care, today announced it released a case ... Electronic Visit Verification™ Solution (EVV™)  for Quality Care ... health company founded in 1996 and has five ... The study details the challenges facing ...
(Date:10/15/2014)... has admitted Johannes Gutenberg University Mainz (JGU) as ... hub continues to maintain a significant nationwide standing ... "The acceptance of Johannes Gutenberg University Mainz as ... milestone in the national and international competition for ... of Rhineland-Palatinate can be proud that Mainz University ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... Oct. 20, 2014 Asterias Biotherapeutics, Inc. ... has signed a Notice of Grant Award (NGA) ... effective October 1, 2014.  The NGA provides for ... the release of additional grant funds pursuant to ... for clinical development of Asterias, product, AST-OPC1. The ...
(Date:10/20/2014)... 20, 2014 PureTech , a science ... healthcare problems, announced today the closing of a ... from Invesco Perpetual, a $120 Billion group of ... PureTech,s existing pipeline forward and to advance new ... scientific creativity to really go for the big ...
(Date:10/19/2014)... The Latin American hardware encryption display market report defines ... and forecast of revenue. This market was valued at ... $2,366.8 million by 2018, at a CAGR of 70.3% ... of the Latin American hardware encryption market report to ... also provides a glimpse of the segmentation of the ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
Cached News: